USPTO serial 79081187
ACTELION
Reviewed by CopyMark Law Group
Reg. 3983464Status 709
- Filing date
- Status date
- Registration date
- Jun 28, 2011
- Examiner
- MCCAULEY, BRENDAN D
- Law office
- GENERIC WEB UPDATE
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ACTELION?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
CH
CH
CH
CH
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Cheryl Foytlin
Cheryl Foytlin Johnson & JohnsonONE JOHNSON & JOHNSON PLAZANEW BRUNSWICK, NJ 08933UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of cardiovascular and pulmonary diseases; pharmaceutical preparations for the treatment of glycolipid storage diseases; Pharmaceutical preparations for the treatment of cerebrovascular diseases; Pharmaceutical preparations for the treatment of inflammatory diseases; Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system and of the peripheral neurological system; Pharmaceutical preparations for the treatment of insomnia and other sleep related diseases; hypnotics and sedatives; Pharmaceutical preparations for the treatment of obesity and eating disorders; Pharmaceutical preparations for the treatment of addiction; Pharmaceutical preparations for the treatment of cognitive disorders; Pharmaceutical preparations for the treatment of gastrointestinal disorders; Pharmaceutical preparations for the treatment of auto-immune disorders; Pharmaceutical preparations for the treatment of digital ulcers; anxiolytics; anti-allergics; anti-infectives | SECTION 71 - CANCELLED | — |
| 044 | Medical services, namely, providing medical information regarding pharmaceutical products and healthcare to healthcare professionals and patients | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Actelion Pharmaceuticals Ltd.
- Other trademarks owned by Actelion Pharmaceuticals Ltd.
- Other trademarks owned by Actelion Pharmaceuticals Ltd
- Other trademarks owned by Actelion Pharmaceuticals Ltd.
- Other trademarks in Class 005
- Other trademarks in Class 044
- Similar marks named ACTELION
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 8, 2026 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Mar 14, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 5, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 5, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 30, 2022 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Sep 30, 2022 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Sep 30, 2022 | INPC | INVALIDATION PROCESSED | — |
| Sep 14, 2022 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jan 14, 2022 | C71T | CANCELLED SECTION 71 | — |
| Jun 28, 2020 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| Apr 30, 2020 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Jun 15, 2018 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 6, 2018 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 6, 2018 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jun 7, 2017 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Jun 7, 2017 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| Jun 6, 2017 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Feb 9, 2017 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Jun 28, 2016 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| May 30, 2013 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 21, 2013 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Nov 22, 2011 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Nov 22, 2011 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 28, 2011 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 28, 2011 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 12, 2011 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 12, 2011 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 24, 2011 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 24, 2011 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Mar 8, 2011 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Mar 1, 2011 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 1, 2011 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 1, 2011 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 1, 2011 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 1, 2011 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Feb 28, 2011 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Feb 5, 2011 | PBTQ | WITHDRAWN FROM PUB OTQR REQUEST | — |
| Jan 25, 2011 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jan 18, 2011 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 14, 2011 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 14, 2011 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 14, 2011 | ALIE | ASSIGNED TO LIE | — |
| Dec 28, 2010 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 30, 2010 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jun 28, 2010 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 28, 2010 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 26, 2010 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 25, 2010 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 23, 2010 | DOCK | ASSIGNED TO EXAMINER | — |
| May 19, 2010 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 19, 2010 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 4, 2010 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 30, 2010 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 29, 2010 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |